chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash started to develop day after receiving vaccine. Pt came back today to report issue 11/06/2023 pt has been using aloe vera, Benadryl ,and cortisone on area with mild improvement. Pt referred to doctor office for further evaluation.
This spontaneous report was received from a physician refers to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were no provided. On unknown dates, the patients were vaccinated with dose of RECOMBIVAX HB (route, lot number and expiration date were not provided). On unknown dates, there was an incorrect product storage as the multiple unspecified patients were administered improperly stored RECOMBIVAX HB. No adverse events were reported. It was unknown if the patients sought medical attention. The outcome of incorrect product storage and no adverse event was unknown. This is one of several reports received from the same source. Additional information has been requested.
Scratchy, red, swollen eyes.  Heaviness on chest with shortness of breath (difficulty breathing).  Fatigue, chills, pale, cough, sore scratchy throat.
Diagnosis: Benign Fascilation Syndrome (BFS), due to chronic muscle spasms. Detected after two EMG studies.
Temp FDA approval only covers 18yo and above.  Had made an appointment for this patient with the expectation of getting Pfizer.  Parent aware and present at the time of vaccination.  The patient waited 15 minutes with no issue.
arthralgia of the lumbo-sacral area; pt recvd 2nd dose 7OCT93-pt separated a dog & raccoon & got blood on hands; pt wants to cont series regardless of events; 29NOV93 f/u cont sereis w/doses from Lots J0265, J0354; all sx resolved;
This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Lung pain), HEADACHE (Headache) and CHILLS (Chills again) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 031M20A) for COVID-19 vaccination. Concurrent medical conditions included Pain in hip. Concomitant products included DICLOFENAC POTASSIUM for Pain in hip, METFORMIN, CLOPIDOGREL, METOPROLOL SUCCINATE, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ), SIMVASTATIN, MELOXICAM, METHOCARBAMOL and SERTRALINE HCL for an unknown indication. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced PULMONARY PAIN (Lung pain), HEADACHE (Headache) and CHILLS (Chills again). The patient was treated with ACETAMINOPHEN (oral) for Headache, Chills and Lung pain, at a dose of 650 milligram every four hours. At the time of the report, PULMONARY PAIN (Lung pain), HEADACHE (Headache) and CHILLS (Chills again) had resolved.    This case was linked to MOD-2021-162150.
3 inch diameter of a red hot slightly swollen area; 3 inch diameter of a red hot slightly swollen area; 3 inch diameter of a red hot slightly swollen area; This is the spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (Batch/Lot Number: ER8733; Expiration Date: 31Jul2021), via an unspecified route of administration on 25Mar2021 08:30 as single dose for covid-19 immunization. The patient had no medical history. The patient had no other products. The patient experienced 3 inch diameter of a red hot slightly swollen area in Mar2021. It had like a 3-inch diameter of a red hot slightly swollen area, the first shot last it for about 3 days. The outcome of events was resolved.  No follow-up attempts are needed. No further information is expected.
This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of Guillain-Barre in a 31-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). On 2 July at 12:00 the subject received 1st dose of BOOSTRIX (.5 ml, unknown route, right arm). On an unspecified date in July 2010, within 2 weeks after vaccination with BOOSTRIX, the subject experienced Guillain-Barre. The subject was hospitalised within 2 weeks of BOOSTRIX administration. The healthcare professional reported that the subject was hospitalised overnight for a while and was discharged on 09 August 2010. At the time of reporting the outcome of the event was unspecified.
mom called pt c/o sore throat, fever of 101, enlarged lymph nodes @ neck c/o pain in testicles area x 12 days p/vax; same sx as in MAY92;
NAUSEA/VOMITING, DIZZINESS, LIGHTHEADEDNESS, SYMPTOMS LASTED APPROX 30 MINS, TREATED WITH COLD COMPRESSES AND REST
Patient states she received the COVID vaccine on 5/13/2021 at 4:00pm, on 5/14/2021 around 10:30am or 11:00am patient started to have dilated eyes, hands froze and where purple with white Raynaud's, stuttering, twitching of the left eye. Patient is still having left eye twitching but other symptoms are better.
mom states pt had high pitched screaming & whining began 130PM 6MAY95;t99.2 gave cool both & APAP
Developed mild symptoms of fatigue 4 hours after dose. Continued to feel fatigue throughout Sunday. Monday developed a cough. Woke up in the night Monday with fever, high body pain, heart palpitations, and trouble catching breathe. Went to emergency room Tuesday October 26th at 8am. Doctors ran labs and tested and are leaning towards me contracting COVID through the vaccine. Sent me home with benzonatate for cough, dexamethasone as a steroid, and azithromycin as a Z pack. Still awaiting results of covid test done Tuesday.
Mother called the pharmacy on 10/17/23 at about 500 pm inquiring who gave her son his vaccine. The vaccinators name was provided, and she said the shot was given too high, and that her son now required physical therapy. No further information was provided.
Pt received Moderna shoot #2 2/11/21. Reports that on 2/12/21 Pt began experiencing chest pain and dyspnea. 911 was called, PT was transported to local Hospital and treated with DX of MI followed by stent placement.
Just the pain of the needle.; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced injection site pain (Verbatim: Just the pain of the needle.). The outcome of the injection site pain was resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.     It was unknown if the company considered the injection site pain to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR052241   Additional Information: GSK Receipt Date: 07-APR-2023 This case was reported by the patient via interactive digital media. After the vaccination with the first dose the patient had just pain of needle. The follow-up could not be possible as no contact details were available. For tolerance of 2nd dose refer case US2023AMR052241. This case is linked with US2023AMR052243 and US2023AMR052242, reported by the same reporter.; Sender's Comments:  US-GSK-US2023AMR052241:same reporter - 2nd dose US-GSK-US2023AMR052243:same reporter US-GSK-US2023AMR052242:same reporter
PAIN AT INJECTION SITE.  ARM SORE AND INJECTION SITE RED AND WARM TO THE TOUCH.
Gianotti Crosti type rash on L arm spreading to R arm soon after, vaccine given on 12/30/21 in AM and rash noted 1/03/22 in AM.
I was diagnosed with Uterine Fibroids.  Previous to vaccine, I did not have any symptoms or predestination for them.  After all the shots received, my hormones and fertility cycle were messed up, and took a while to get back to normal.
Headache; Body ache; Tiredness; Congestion; Chill; Mild throat pain; Feeling tired; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 01Apr2021 at 16:30 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure and mild cardiomyopathy. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) 20 (units unspecified), diltiazem (MANUFACTURER UNKNOWN) 60 mg and trazodone (MANUFACTURER UNKNOWN) 50 mg; all from unknown date for unknown indications. The patient previously received amoxicillin and codeine on unknown date for an unspecified indication and the experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 07:00, the patient experienced started feeling tired. On 07Apr2021, the patient experienced body ache, tiredness, congestion, chill and mild throat pain. On 08Apr2021, the patient experienced headache. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events feeling tired, body ache, tiredness, congestion, chill, mild throat pain and headache were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient was given the varicella vaccine SQ in the Left arm.  The next day had a large red welt there and the site was very painful.  Pt had no fever.  2 days after injection the patient was examined at the clinic.  The area was erythematous and indurated to a size 7 cm wide and 5.5 cm high.  The patient was advised to take OTC Benadryl as needed and tylenol for pain.
A rash appeared on my arm about 6 hours after receiving vaccine. Woke up on 10/26 with lymph node in left arm pit swollen and body aches; began taking Benadryl. Visited urgent care on 10/26 specifically for side effects of vaccine; received topical cream for rash, told to ride out lymph node swelling, and continue taking Benadryl. Today, on 10/28, no change to symptoms other than body no longer aches.
Headache chills, fatigue, injection site pain and swelling, loss of taste Narrative:
3 hrs p/adm of vax; pt began prolonged crying 2-3 hrs @ a time; loss ofappetite (approx 1/2 of previous intake); crying & loss of appetite lasted for 9 days; crying was virtually all day, every day; pt could not be comforted;
8/16 Paient Denies adverse Reaction to 05.mL dose instead of 0.3ml dose
Numbness and tingling in lips and tongue - post 1 hour Dizziness day 2-3 Fever Low grade 99.4 post 1 hour Achiness day 4-5 Fever 100.4 day 5
Inflamed, red, warm, and extremely painful right arm around injection site. Chills, fever, nausea, fatigue, muscle aches, headache, and all of my skin hurt... weirdest feeling
Cough and wheeze, hypoxia, treated with albuterol, atrovent and prednisolone with good response.
pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD; gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-DEC-2022; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-DEC-2022) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-DEC-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-DEC-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD) and PRODUCT STORAGE ERROR (gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-DEC-2022).    It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant medication were reported.  Vial size was 0.4 ml per vial. The vial was initially stored in the refrigerator on 23-Dec-2022.  Dates of administration of vaccine were 26-Jan-2023, 27-Jan-2023, 30-Jan-2023, 31-Jan-2023, 2-Feb-2023, 6-Feb-2023, 8-Feb-2023, 10-Feb-2023, 13-Feb-2023, 14-Feb-2023, 16-Feb-2023, 17-Feb-2023, 21-Feb-2023. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter.  This case is of patient 37 out of 42 patients, as described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-718298 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718298:patient no. 01 (Master case)
Chills 6 hours Headache I4 hours Fever 100.8  4 hours Dizzyness 6 hours High Pulse  101 High blood pressure 164-89  6 hours
Dizziness, light headed, and throat started feeling a slight constriction.  They gave me Benadryl and after about 20 minutes my throat felt better
We have been dealing with major sleep disturbance and night wakefulness in the 6 days since patient was vaccinated. Patient has been awake from 1 am to 5 am every night since getting the MMR and Chickenpox vaccines. If we can get him back to sleep at 5, he will only sleep until 6. Some days he is awake from 1 am or 3 am and never goes back to sleep. He cries when we lay him down and appears to immediately awaken out of a sound sleep. He has felt warm and been running a low grade temp-- 100-101 F on/off since the vaccinations. We have been treating with Ibuprofen 1-2 times a day. He is clearly exhausted and very irritable from lack of sleep.
Hemoglobin 9.3 MCV,MCH, MCHC  low A/G ratio 2.6, calcium down on point, LDH down 50 points, weakness, dizziness, voice hoarse, VO2 very low, shortness of breath Rejected for blood donation. Previous 15 years never shown low hemoglobin
got first dose / may have had the series about 3 years ago / any danger to getting this twice?; This case was reported by a consumer via interactive digital media and described the occurrence of extra dose administered in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (might had the series about 3 years ago from the date of reporting).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not reported. The patient's wife stated that, they thought, the patient might have the series about 3 years ago from the date reporting and still got the Shingrix which led to extra dose administered. She asked, was there any danger to getting this twice.
her blood test showing her "levels were low"; she is pregnant; injection site was red and swollen; injection site was red and swollen; This spontaneous prospective pregnancy report was received from a 22-year-old female patient, who was referring to herself. She had none concomitant medications, pertinent medical history or drug reactions/allergies reported.  On an unknown date, when she was a child, the patient was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck)(VARIVAX), 1 injection (strength, route of administration, lot number and expiry date were not provided) for prophylaxis. On an unknown date, unspecified blood test was performed, which showed that "her levels were low" (not further clarified). Due to the event, she was recommended to retake the vaccine to "boost her levels". On 09-AUG-2020, the patient performed the pregnancy test, which was negative. On 11-AUG-2020, the patient was vaccinated with another dose (however, she also stated it was her first dose - discrepant information) of varicella virus vaccine live (oka/merck)(VARIVAX), 1 injection in the upper arm (strength, route of administration, lot number and expiry date were not reported) to boost levels.  On approximately 12-AUG-2020 (reported as the day after the vaccination), the injection site became red and swollen. On 26-AUG-2020, the patient performed another pregnancy test, which was positive. On 27-AUG-2020, the patient had a doctor's appointment and it was confirmed that she was pregnant. The patient's last menstrual period (LMP) was reported as 22-JUL-2020, estimated date of conception was calculated as 05-AUG-2020 and estimated date of delivery (EDD) was calculated as 28-APR-2021. The pregnancy outcome was pending. The fetal outcome was unknown. The outcome of the events of levels were low, injection site redness and injection site swelling was not reported (however the patient stated that injection site swelling and redness lasted for 4 days).  The relatedness between the events and the suspect vaccine was not reported.
Red area at site of immunization on right thigh. Has "large red welt like bump, very tender and covers a 5-6" area"
Resident noted with skin rash  on right shin and right side of the neck.   Loratadine Tablet 10 MG daily x 10 days ., Betamethasone Valerate External Cream 0.1 %  BID x 10 days were prescribed.
33 year old female with no preexisting health conditions received her first Moderna vaccine on Saturday, March 13 at 9am in the left deltoid. Patient immediately felt weird after receiving the vaccine - tingling and accelerated heart but no intervention occurred. Patient started with the basic side effects headache, sore arm, shakes/chills and fatigue/weakness and brain fog.  Starting around 24-36 hours after injection patient started to notice mild muscle spasms and tingling sensations. That has progressed to full paresthesia of the arms/hands and legs/feet. Patient also states paresthesia occurs in the face, neck, lips, torso and even occasionally in ears - but these seem less severe and wax and wane. The patient noticed vision changes and muscle fatigue described as muscles feeling like "jello." Due to weakness, patient also complains of continued brain fog. The patient is also occasionally getting twitching and pulsating muscles.   The patient describes the neuropathy "like my limbs are defrosting." It was described as cold tingling but at times intense. Patient noticed that cold temperatures make it more pronounced and movement helps to temporarily make it seem a bit better.
Day 1: sore at injection site Day 2: swollen armpit lymphnode, fatigue, headaches Day 3: lymphnode at peak discomfort, brain fog, fatigue, headaches, period spotting, vivid dreams, hot/cold flashes  Day 4: swollen lymphnode, fatigue, spotting, throat felt raw, spotting Day 5 (today): swollen lymphnode, spotting Note: fatigue and malaise came together in waves
Stabbing and shooting pains in arms and legs, bruise pain with no visible signs of bruising that disappears within hours, electrical sensations in fingertip.
patient had shingles like eruption to bilateral cheeks, lesions in various stages of blistering/scabbing, nerve like pain associated with them
feeling a little "woozy"; fever; This is a spontaneous report from a contactable consumer or other non hcp via internet source. A 13-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Unknown and Expiration date Unknown) second dose, via an unspecified route of administration on an unspecified date, as single dose for Covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,Formulation: Solution for injection, Lot Number: Unknown and Expiration date Unknown) on an unspecified date, as single dose for COVID-19 immunization. The reporter stated that his/her friend mentioned on a zoom that on an unspecified date. The patient had fever after his second shot of vaccine and was feeling a little "woozy". The reporter assumed that he was referring to the Pfizer Vaccine because it was the only authorized one for that age group and that was all the information that reporter had. The outcome of the events was outcome of unknown.  Information on the lot/batch number has been.
Got chills, soreness not so much at injection site, which is considered normal, but very sore underneath upper arm. Painful to raise right arm.
11/01/2001 Telephone call, continued to have dull headache, back to work.
Patient with recurrent ITP exacerbations (usually after viral illness) developed flare of condition after receiving these 3 vaccines. Developed petechiae 3 days after their receipt. Also developed URI sxs the night of receiving the vaccinations.12/4and 12/8/2009 MD records  11/3 and 11/16/2009, MR 10/29-30/2009 and lab results, patient with a hx of Idiopathic Thrombocytopenia Purpura, had a flare  post vaccines with a drop in plt ct to 22,000, tx'd with high-dose steroids and by 11/16/2009 plt count had recovered to baseline, will repeat CBC in 2 weeks
24 hrs after administration of varicella and MMR in left arm pt had swelling, erythema and pain.
Patient reported to physician with heart palpitations. Was hooked to a heart monitor to check rhythms and for any sign of a cardiac event. Started on magnesium and symptoms resolved. Vaccine was the only new thing in her regimen (no new meds, disease states, etc.).
About a month after receiving my second COVID-19 vaccination my left arm starting hurting periodically. It has not stopped hurting since my second vaccination. My shoulder will hurt then sometimes it will move to the back of my left arm then sometimes it will hurt on the inside of my elbow. My left arm even seems weaker than my right when I am using it do chores out at the horses or helping my residents where I work. I have not went in to see a Doctor about it, I'm not sure what they will be able to do about it. Tylenol or Advil does  not help.
Fever of 103.3 12 hours after injection  fever has continued in to the next day he has been given ibuprofen to ease the discomfort and tempature
02/11/22 presents to Birth Center Triage for "Amniotic fluid leaking" "37w2d". PMHx of "Anemia" "CESAREAN Section"
7 year old previously healthy male who presents with concern for MIS-c. History obtained from chart review and his mother. PT was diagnosed with COVID on 12/21/21 at which time he was asymptomatic (was tested because other family members were ill). Mom reports that he received a COVID vaccine about one week after he tested positive. Since that time (~3 weeks ago), PT has been more fatigued and has had headache and abdominal pain. He developed a rash (erythematous pruritic palpable bumps on his arms, legs, chest and back that has improved and is now just on the back of his arms). He was seen at an ED on 1/9/22 after two days of fever (~102), rash and URI symptoms.